Several members of the retino-sympathetic CRC showed elevated transcript levels after ATRA treatment of these cells, but differentiation did not proceed because of sustained high levels of MYCN expression driven by the HAND2 enhancer (fig. The gene discussed is MYCN; the disease is colorectal carcinoma.